GastroenterologyNews.net

Gastroenterology Xagena

Search results for "Colorectal cancer"

A study, led by David S. Alberts, of the Arizona Cancer Center at Tucson, found that Ursodeoxycholic Acid ( UDCA ) treatment is associated with a 39% relative reduction in the risk of recurrence of hi ...


A study of gender and risk factors for colorectal cancer reveals that while both tobacco and alcohol increase risk for colorectal cancer, women who smoke are at higher risk. Anna L. Zisman, of Evanst ...


A study revealed that patterns in diet may effect the development of colorectal adenomas, or precancerous polyps of the colon. In this study, over 1500 patients underwent baseline colonoscopy to r ...


Two studies, published in the Clinical Gastroenterology and Hepatology, have showen that prescription painkillers are effective in easing the pain of patients with dormant inflammatory bowel disease ( ...


Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with adva ...


A subset of colorectal cancers responds to anti-epidermal growth factor receptor ( anti-EGFR ) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR ther ...


In two large studies, the association between Acetylsalicylic acid ( Aspirin ) use and risk of colorectal cancer was affected by mutation of the gene BRAF, with regular Aspirin use associated with a l ...


PAVES ( Pegfilgrastim and Anti-VEGF Evaluation Study ) trial has evaluated Pegfilgrastim ( Neulasta ) in 845 patients receiving FOLFOX or FOLFIRI and Bevacizumab ( Avastin ) for the first-line treatme ...


Final data from IMPACT study provide proof of principle for new treatment approach. The findings confirm the biological action of the drug called MGN1703 and suggest it may be possible to identify whi ...


Bayer HealthCare has announced that the European Commission has approved Stivarga ( Regorafenib ) tablets for the treatment of adult patients with metastatic colorectal cancer ( mCRC ) who have previo ...


In the past decades, prophylactic colectomy to prevent development of colorectal cancer substantially has improved prognosis in patients with familial adenomatous polyposis ( FAP ). The mortality patt ...


The objective of a study was to evaluate the impact of a diet and physical activity intervention ( BeWEL ) on weight change in people with a body mass index greater than 25 weight (kg) / height (m)2 a ...


Metastatic colorectal cancer ( mCRC ) is commonly treated with 5-Fluorouracil, Folinic acid, and Oxaliplatin or Irinotecan. The multitargeted kinase inhibitor, Regorafenib ( Stivarga ), was combined ...